Escourolle and Poirier's Manual of Basic Neuropathology 6th Edition Francoise Gray MD (Editor) - Quickly Access The Ebook and Start Reading Today
Escourolle and Poirier's Manual of Basic Neuropathology 6th Edition Francoise Gray MD (Editor) - Quickly Access The Ebook and Start Reading Today
com
https://textbookfull.com/product/escourolle-and-poiriers-
manual-of-basic-neuropathology-6th-edition-francoise-gray-
md-editor/
OR CLICK HERE
DOWLOAD EBOOK
https://textbookfull.com/product/basic-graph-theory-1st-edition-md-
saidur-rahman-auth/
textbookfull.com
https://textbookfull.com/product/the-md-anderson-manual-of-medical-
oncology-3rd-edition-hagop-m-kantarjian/
textbookfull.com
https://textbookfull.com/product/neuropathology-of-drug-abuse-andreas-
buttner/
textbookfull.com
https://textbookfull.com/product/practical-management-of-
pain-6e-may-19-2022-6th-edition-benzon-md/
textbookfull.com
Total Knee Arthroplasty A Technique Manual 3rd Edition
Scott Md
https://textbookfull.com/product/total-knee-arthroplasty-a-technique-
manual-3rd-edition-scott-md/
textbookfull.com
https://textbookfull.com/product/the-complete-google-manual-6th-
edition-coll/
textbookfull.com
https://textbookfull.com/product/neuropathology-2nd-edition-b-k-
kleinschmidt-demasters/
textbookfull.com
https://textbookfull.com/product/the-complete-cloud-computing-
manual-6th-edition-coll/
textbookfull.com
i
EDI T E D B Y
F R A NÇ O I S E G RAY, MD , P H D
PROFES SOR OF PAT HOL OGY ( RE T.) , FACULT É DE M É D E C I N E PA R I S D I D E R O T, U N I V E R S I T É PA R I S ,
D IDER OT, S OR BONNE PARI S CI T É , PARI S, F RANCE
NEUROPATHOLOGI ST, DE PART M E NT OF PAT HOL OGY, LA R I B O I S I È R E H O S P I TA L ( R E T. ) , A P H P,
PARIS , FRANCE
C H A R L E S D U YC K A ERTS , MD , P H D
PROFES SOR OF PAT HOL OGY, UNI VE RSI T Y PI E RRE E T M A R I E C U R I E , PA R I S , FR A N C E
D IR EC TOR, NEUR OPAT HOL OGY L ABORAT ORY, PI T I É / S A LP Ê T R I È R E H O S P I TA L, PA R I S , FR A N C E
U M B E R T O D E G IRO LA MI, MD
PROFES SOR OF PAT HOL OGY, HARVARD M E DI CAL SC H O O L, B O S T O N , M A , U S A
NEUROPATHOLOGI ST, BRI GHAM AND W OM E N’S HO S P I TA L, B O S T O N , M A , U S A
1
1
Oxford University Press is a department of the University of Oxford. It furthers
the University’s objective of excellence in research, scholarship, and education
by publishing worldwide. Oxford is a registered trade mark of Oxford University
Press in the UK and certain other countries.
This material is not intended to be, and should not be considered, a substitute for medical or other professional advice. Treatment for the
conditions described in this material is highly dependent on the individual circumstances. And, while this material is designed to offer
accurate information with respect to the subject matter covered and to be current as of the time it was written, research and knowledge about
medical and health issues is constantly evolving and dose schedules for medications are being revised continually, with new side effects
recognized and accounted for regularly. Readers must therefore always check the product information and clinical procedures with the
most up-to-date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and
safety regulation. The publisher and the authors make no representations or warranties to readers, express or implied, as to the accuracy or
completeness of this material. Without limiting the foregoing, the publisher and the authors make no representations or warranties as to the
accuracy or efficacy of the drug dosages mentioned in the material. The authors and the publisher do not accept, and expressly disclaim,
any responsibility for any liability, loss or risk that may be claimed or incurred as a consequence of the use and/or application of any of the
contents of this material.
9 8 7 6 5 4 3 2 1
Contents
• v
8. Pathology of Degenerative Diseases of 12. Pathology of Skeletal Muscle 299
the Nervous System 186 Romain Gherardi, Anthony A. Amato,
Charles Duyckaerts Hart G. Lidov, and Umberto De Girolami
vi • C ontents
vi
Foreword
Most textbooks of medicine, even the most is inexorable, reflecting as it does the increasingly
venerated, undergo a new edition every 5 years complex biology, pathophysiology, and therapeutics
or even longer. This interval reflects the relatively of the various fields. This process, which occurred
slow progress in most fields. After all, change in in internal medicine in the twentieth century, is
the practice of medicine usually reflects the ar- now in full bloom in the twenty-first century. For
duous process of preclinical basic science followed this reason, a new edition of Escourolle and Poirier’s
by the lengthy testing of drugs in animals and then Manual of Basic Neuropathology has been hatched in
humans. As most clinical trials are negative, only only 5 years.
a small number of real changes occur in less than In generations past, the basic science of neuro-
a decade. However, this viscous process does not science was neuropathology. Over time, other fields,
hold in neuroscience. Driven mainly by advances such as genetics, imaging, neuropharmacology, and
in molecular biology, cell biology, and genetics, molecular biology have become vital to the training
the clinical neurosciences (neurology, neurosur- and practice of the clinical neurosciences. But, con-
gery, and psychiatry) are experiencing dramatic trary to becoming extinct, neuropathology has in-
change. Together with cancer, the neurosciences are corporated these newer disciplines and has, in effect,
undergoing a transformation that is analogous to reclaimed its leadership role in the understanding
cardiology in the last century. Patients are now re- and ultimately treatment of disorders of the nervous
ceiving the benefits of this momentum in the form system. In the sixth edition of the now classic
of treatments for virtually every category of nervous textbook, Escourolle and Poirier’s Manual of Basic
system disorder. The modern neurology department Neuropathology, Professors Umberto De Girolami,
is now differentiated into 15–20 divisions. This pro- Françoise Gray, and Charles Duyckaerts have
cess may be bemoaned by the older generation, but embodied this trend by creating what is, in effect,
• vii
a concise approach to the understanding of all the familiar manner, starting with a chapter on the basic
major categories of nervous system disease. In a very principles of the pathology of the nervous system.
creative and truly unique manner, they have added This is followed by individual chapters on tumors,
distinguished clinicians to many of the chapters to trauma, vascular diseases, infections, prion diseases,
ensure relevance of the basic information to the demyelinating processes, degenerative diseases, ac-
actual practice of medicine. This reflects the fact quired and inherited metabolic diseases, congenital
that many of the major questions in diseases of the malformations, muscles, nerves, and diseases of the
nervous system, such as regarding paralysis, pain, pituitary gland. The book ends with an appendix
disorders of consciousness, and cognitive decline, on commonly used neuropathology techniques. As
do not fit neatly into any one of the old categories examples of the new approach, the distinguished
that were artificially created in the past, as they no myologist Anthony Amato cowrote the chapter on
longer reflect the relevant pathobiology. disease of skeletal muscle, as did the eminent neu-
Interdisciplinary neuroscience is the wave rosurgeon Edward Laws for the pituitary chapter
of the future if we are to unlock the mysteries and the venerated Steven Feske for the vascular
of neurodegeneration, neuroinflammation, and diseases chapter. As Gilbert and Sullivan’s Pooh-Bah
aging. In our own center, this is reflected in the re- famously said, this adds “artistic verisimilitude to an
cent formation of a Program in Interdisciplinary otherwise bald and unconvincing narrative.”
Neuroscience, which is meant to facilitate re- Indeed, this new edition of Escourolle and Poirier’s
search, clinical care, and education in areas that Manual of Basic Neuropathology is much more than
fall between the classic disciplines, allowing for a that. It is, in fact, a concise textbook of the modern
multiperspective approach to learning the causes and neurosciences, one that will be read and referred
creating preventive and curative strategies for the fu- to by the next generation of all those students and
ture. As one salient example, the science underlying physicians interested in diseases of the nervous
neurodegeneration and repair has vital relevance to system.
a vast array of diseases, such as amyotrophic lateral
Martin A. Samuels, MD, FANA, FAAN, FRCP,
sclerosis, Alzheimer disease, and Parkinson disease.
MACP, DSc (hon)
In the past, these would have been considered en-
Director, Program for Interdisciplinary
tirely separate illnesses, each cared for in different
Neuroscience
divisions, such as neuromuscular diseases, cognitive
Chair, Department of Neurology
and behavioral neurology, and movement disorders.
Brigham and Women’s Hospital
It is now clear that the basic science of each of these
Miriam Sydney Joseph Professor of Neurology
disorders is shared. Immunology has also taken a
Harvard Medical School
major role in understanding diseases as apparently
Boston, Massachusetts
disparate as stroke, dementia, and epilepsy.
USA
Escourolle and Poirier’s Manual of Basic
Neuropathology is organized in its successful and
viii • F oreword
ix
The first two French editions of the Manuel de This sixth edition of the manual attempts
Neuropathologie, published in 1971 and 1977, to maintain the general intention of Professors
were conceived, written, and edited by Raymond Escourolle and Poirier for the first and subsequent
Escourolle and Jacques Poirier. After the death editions of the monograph, that is, to provide, for
of Raymond Escourolle in 1984, Françoise Gray the reader resident-trainee and staff member, a basic
joined Jacques Poirier for the third edition; in ad- description of the lesions underlying the diseases of
dition, Jean-Jacques Hauw and Romain Gherardi the nervous system and to limit pathophysiological
contributed to selected chapters. The first three considerations to essential principles. Historical,
editions reached the English-speaking public thanks clinical neurologic and radiologic imaging data,
to the friendship and translating ability of the now- once again, have been deliberately excluded, as well
deceased Lucien Rubinstein. For the fourth edition, as bibliographic reference listings. This important
Umberto De Girolami joined as co-editor, and the body of information essential for the practice of
scope of the monograph was expanded with the col- neuropathology can be obtained in the many com-
laborative efforts of multiple experts throughout the prehensive treatises on the subject now readily avail-
world to write the English language text. Jacques able. We also have made the assumption that the
Poirier retired, and Charles Duyckaerts then agreed reader has some familiarity with general concepts of
to join the editorial team for the fifth and now the neuroanatomy, neurohistology, and the principles of
sixth edition. For this sixth edition, there have again anatomic pathology as well as clinical neurology.
been changes in authorship of several chapters in With these guidelines in mind, our aim has been
response to the changing status of senior authors to produce a text that mainly presents those labo-
and the need to recruit active investigators to ratory aspects of neuropathology that are morpho-
replace them. logical (and molecular, where appropriate) and to
• ix
demonstrate these with accurate descriptions and metabolic disorders, developmental disorders,
good illustrations, all within the scope of a concise and neuromuscular diseases. Morphologic
and inexpensive “manual.” neuropathologic data, obtained at biopsy or
For several specific reasons, we think that the at postmortem examination, have therefore
time is now right for a new edition since the last needed to be integrated with this new knowledge
one in 2014. Over the past several years, specialty for the reinterpretation and reclassification of
training in neurology, neurosurgery, and pathology many diseases. For example, neuropathologic
has very much changed throughout much of the information obtained at biopsy, combined
world, such that in these disciplines, less time is with molecular biology and genetic data, is
being devoted to neuropathology. This has been due now required for the diagnosis, prognosis, and
in large part to the tremendous expansion of know- guidance of the choice of treatment modalities in
ledge in allied subspecialty areas, requiring that brain tumors.
more time be devoted to them. Thus, the trainee in • Last, an urgent responsibility to present an
these disciplines is now very much in need of a con- updated synopsis of neuropathology is that this
cise introductory text. knowledge is important to allied disciplines, as
In addition, several other important changes in there is constant need for surveillance of newly
medicine and society have had an impact on the field emerging diseases, including infectious and
of neuropathology and demand being addressed in iatrogenic ones.
this text.
We need to thank first of all Susan Pioli, who al-
• For a variety of social and scientific reasons, though now retired from the publishing business,
autopsy studies are currently being performed was instrumental in prior editions and led us to Craig
much less frequently than in years past. This Panner and his colleagues with Oxford University
change has been brought about in part because Press, who has given fundamental support. Second,
the progress in radiologic imaging, both we thank present and past contributing authors and
structural and functional, has decreased the their staff for the text and illustrations provided in
need to draw on clinico-anatomic correlations this new edition.
derived from postmortem data to guide clinical In the Introduction to the first edition, Professors
practice. Oddly enough, conversely, autopsy- Escourolle and Poirier offered an apology to the
derived knowledge of the anatomic distribution reader that is still valid some half a century later:
and the neuropathologic basis of lesions
continues to be a valuable body of information The compilation of a basic work designed to
for the interpretation of imaging data. To familiarize physicians-in-training with such a
support this aim, we have amply made use of highly specialized discipline as Neuropathology
macroscopic illustrations and whole-brain entails two opposing risks: in attempting to
celloidin/paraffin-embedded sections from our compress the maximum amount of information
archives. within the minimum space, the text is liable to
• Progress in molecular biology and genetics has become unintelligible to beginners; if on the con-
revolutionized the laboratory diagnosis of many trary, one tries to maintain too elementary a
groups of neurological diseases. Neuropathology level, the danger is that only the obvious will be
stands at the vanguard of the development and stated. In presenting to the non-initiated reader
implementation of these diagnostic studies. In the neuropathological information that some may
last decade, progress in immunohistochemistry find too simple, we have preferred the hazard of
methods for in situ identification of abnormal the second pitfall.
proteins and the enormous advances in molecular
biology to uncover specific gene mutations have Françoise Gray
led to greater understanding of many hereditary Charles Duyckaerts
neurologic diseases, including degenerative and Umberto De Girolami
x • preface
xi
Contributors
• xi
Fabrice Chrétien, MD, PhD Françoise Gray, MD, PhD
Professor of Histology, Université Paris Descartes, Professor of Pathology (ret.), Faculté de médecine
Paris, France Paris Diderot, Université Paris, Diderot,
Neuropathologist, Laboratoire de Neuropathologie, Sorbonne Paris Cité, Paris, France
Centre Hospitalier Sainte Anne, Paris, France Neuropathologist, Department of Pathology,
Unité de Neuropathologie Expérimentale, Lariboisière Hospital (ret.), APHP, Paris, France
Institut Pasteur, Paris, France
Brian Harding, MA, DPhil, BMBCh, FRCPath
Pedro de Sá Cavalcante Ciarlini, MD Professor of Pathology and Laboratory Medicine,
Auxiliary Professor of Pathology, Federal University University of Pennsylvania, Philadelphia, PA, USA
of Ceará, Sobral, CE, Brazil Neuropathologist, Children’s Hospital of
Pathologist/Neuropathologist, Laboratório Philadelphia, Philadelphia, PA, USA
Clementino Fraga, Fortaleza, CE, Brazil
Jean-Jacques Hauw, MD
Umberto De Girolami, MD Professor of Pathology (ret.), Pierre et Marie Curie
Professor of Pathology, Harvard Medical School, University, Paris, France
Boston, MA, USA Neuropathologist (ret.), Pitié-Salpêtrière Hospital,
Neuropathologist, Brigham and Women’s Hospital, Paris, France
Boston, MA, USA Académie Nationale de Médecine, Paris, France
Charles Duyckaerts, MD, PhD James W. Ironside, MD
Professor of Pathology, University Pierre et Marie Professor of Clinical Neuropathology (ret.), School
Curie, Paris, France of Clinical Sciences, University of Edinburgh,
Director, Neuropathology Laboratory, Edinburgh, UK
Pitié/Salpêtrière Hospital, Paris, France
Gregory Jouvion, PhD
Steven K. Feske, MD Unité de Neuropathologie Expérimentale, Institut
Associate Professor of Neurology, Harvard Medical Pasteur, Paris, France
School, Boston, MA, USA
Hans Lassmann, MD, PhD
Chief, Cerebrovascular Division, Department of
Professor of Neuroimmunology, Medical
Neurology, Brigham and Women’s Hospital,
University of Vienna, Vienna, Austria
Boston, MA, USA
Chairman, Department of Neuroimmunology,
Romain Gherardi, MD Center for Brain Research, Vienna, Austria
Professor of Histology, Paris-Est University,
Edward R. Laws, Jr., MD, FACS
Créteil, France
Professor of Neurosurgery, Harvard Medical
Neuropathologist, Henri Mondor University
School, Boston, MA, USA
Hospital, Créteil, France
Neurosurgeon, Brigham and Women’s Hospital,
Hans H. Goebel, MD Boston, MA, USA
Professor of Neuropathology (ret.),
Hart G. Lidov, MD, PhD
Johannes Gutenberg University,
Associate Professor of Pathology, Harvard Medical
Mainz, Germany
School, Boston, MA, USA
Consultant Neuropathologist, Institute
Neuropathologist, Boston Children’s Hospital,
of Neuropathology, Charité, Berlin,
Boston, MA, USA
Germany
Keith L. Ligon, MD, PhD
Jeffrey A. Golden, MD
Associate Professor of Pathology, Harvard Medical
Ramzi S. Cotran Professor of Pathology, Harvard
School, Boston, MA, USA
Medical School, Boston, MA, USA
Neuropathologist, Dana-Farber Cancer Institute/
Chair of Pathology and Neuropathologist, Brigham
Brigham and Women’s Hospital, Boston,
and Women’s Hospital, Boston, MA, USA
MA, USA
xii • C ontributors
xi
C ontributors • xiii
1
1
Basic Pathology of the Central
Nervous System
PE D RO D E SÁ CAVA LC A N T E C IA R L IN I, D A NIEL L E SEIL HEAN , UMBERTO DE GIROL AMI,
AN D F RA N ÇO I SE G R AY
• 1
1 .1.1 Basi c c e l l u l a r
r e acti ons to C NS i n j u ry
1.1 . 1 . 1 . N E UR ON A L L ESI O NS
Neuronal injury may be sufficiently severe to result in
irreversible damage (cell death) or may be transient,
or minimal, and cause reversible functional damage.
Destruction of neurons may be focal or extend dif-
fusely, involving many populations of neurons
throughout the nervous system. In acute neuronal
injury, when the tissue is examined stained with he-
matoxylin and eosin (H&E) at a relatively short time
after a lethal insult to the cell (12–24 hours or some- FIGURE 1.1 Two neurons undergoing apoptosis
what longer), one observes eosinophilia of the cyto- are positively stained by in situ end labeling to demon-
plasm, shrinkage and hyperchromasia of the nucleus, strate internucleosomal DNA fragmentation. In one
and disappearance of the nucleolus; subsequent to neuron, on the left, only the nucleus is stained, whereas
the disintegration of the cell, neuronophagia by scav- in the other, which is at a later stage of the programmed
enger cells is evident at a later time interval (days cell death process, the entire cell body is stained.
later). In chronic diseases, evidence of cell death is Compared to a normal neuron, on the right, both ap-
recognized morphologically as neuronal “cell loss” optotic neurons have similar morphological features
or alternately (as “atrophy”) on macroscopic exam- and show a pyknotic nucleus and shrunken cytoplasm.
ination when the irreversible injury has occurred
relatively slowly (months or years) and has progres- amyotrophic lateral sclerosis). It is also seen in anter-
sively involved increasing numbers of cells. In some ograde and retrograde trans-synaptic degeneration,
degenerative diseases of the nervous system where as may occur in the lateral geniculate body following
there is progressive loss or damage of neurons over a lesion of the optic nerve.
variable time periods, the affected cells have distinc- Programmed cell death (apoptosis) is an active,
tive morphologic hallmarks (e.g., neurofibrillary de- genetically controlled, energy-consuming process
generation, neuronal storage of metabolic products, frequent in neurodegeneration and initially involves
disorders associated with intracellular inclusions). the nucleus of the cell. Neurons undergoing simple
Nerve cell loss (i.e., reduction in the number of neuronal atrophy or apoptosis have similar mor-
cell bodies in a particular brain region as compared phologic features and may show positive in situ end
to normal) when it involves less than 30% of the labeling of internucleosomal DNA fragmentation
normal cell population, may be difficult to ascertain (Fig. 1.1) or be demonstrable by activated caspase
in the absence of rigorous morphometric analysis. 3 immunostaining.
Furthermore, precise assessment depends on con- Nerve cell atrophy should not be mistaken with
sideration of the thickness of the section and on the what is referred to as “dark neurons.” This phenom-
normal cytoarchitectonics of the region examined. enon is now recognized to be an artifactual change
of the neuron cell body, seen particularly in brain
1.1.1.1.1. Nerve cell atrophy. Neuronal at- biopsies fixed in formalin by immersion, and is
rophy is the descriptive term that is given to a wide characterized by shrinkage of the neuronal cyto-
range of irreversible neuronal injuries that give rise plasm and a deeply stained, irregularly-shaped nu-
to a relatively slowly evolving death of the cell. cleus, without other cellular alterations.
Neuronal atrophy is characterized morphologically
by retraction of the cell body with diffuse basophilia 1.1.1.1.2. Acute neuronal necrosis (anoxic/
of the cytoplasm and pyknosis and hyperchromasia ischemic neuronal change). Acute neuronal ne-
of the nucleus of the neuron, in the absence of an crosis (anoxic/ischemic neuronal change) cell death
inflammatory reaction. Neuronal atrophy is thought occurs in not only a wide range of acute injuries, in-
to occur in many degenerative disorders that in- cluding anoxia and ischemia, but also many other
volve several interconnected neuronal systems (i.e., acute pathological processes (e.g., hypoglycemia
multiple-system atrophy, Friedreich ataxia, and or exposure to excessive amounts of excitotoxic
FIGURE 1.2 Acute ischemic nerve cell change FIGURE 1.3 Ferruginization (mineralization)
(H&E). Eosinophilic, shrunken cytoplasm and of the neurons at the edge of an old hemorrhagic
hyperchromatic nucleus. infarct (H&E).
neurotransmitters). Unlike apoptosis, the predom- axon (retrograde degeneration or axonal reaction).
inant cellular changes in acute neuronal necrosis Subsequent recovery of normal cell morphology or,
involve the cytoplasmic organelles and the cell conversely, further progression to nerve cell degen-
membrane, which ruptures, leading to cell death. eration depends on the reversibility of the axonal
In experimental animal studies and in carefully lesion (Fig. 1.5). Central chromatolysis may also be
studied human tissue at postmortem, the following seen in upper motor neurons, but the phenomenon
sequence of changes is noted by light and electron is rare and difficult to interpret correctly. Axonal
microscopy over the course of 12 to 24 hours after lesions of neurons whose axons do not leave the
the insult: (a) cytoplasmic microvacuolization due confines of the CNS apparently either do not pro-
to swelling of mitochondria and endoplasmic retic- duce changes in perikaryal cell-body morphology or
ulum; (b) shrinkage of the cell body with retraction result in a “simple” type of atrophy. Oddly enough,
of the cellular outlines and disappearance of Nissl some metabolic disorders that do not a priori affect
bodies with eosinophilic condensation of the cyto- axons (e.g., Wernicke’s encephalopathy, pellagra en-
plasm (“red neuron”); (c) condensation of nuclear cephalopathy, and porphyria) may be accompanied
chromatin and nuclear pyknosis (Fig. 1.2); (d) late by central chromatolysis in cortical neurons.
disappearance of the nuclear chromatin, resulting A confident diagnosis of central chromatolysis
in increased acidophilia of the nucleus, which requires comparison with the normal morphology
appears to merge into the surrounding cytoplasm
(karyorrhexis).
Occasionally, dead neurons, especially those
adjacent to old, mostly hemorrhagic, infarcts or to
traumatic scars, become encrusted with basophilic
mineral deposits, chiefly iron and calcium salts.
This condition is referred to as mineralization or
ferruginization of neurons (Fig. 1.3).
Recovery
Cell death
FIGURE 1.7 Fenestrated neuron in a case of olivary
Stages of hypertrophy (Nissl stain).
hyperchromasia
FIGURE 1.5 Nerve cell changes resulting from cen-
tral chromatolysis. 1.1.1.1.5. Binucleated neurons. Binucleated
neurons are seen rather infrequently, sometimes
under normal circumstances, or otherwise at the
of the affected gray matter structure, because the edge of old focal destructive lesions, as a dysplastic/
nerve cell body in some nuclei (e.g., the mesence- malformation phenomenon (e.g., tuberous sclerosis),
phalic nucleus of the fifth cranial nerve, Clarke’s or in certain neoplasms (e.g., ganglion cell tumors).
column) normally contains rounded neurons with
marginated Nissl bodies. 1.1.1.1.6. Neuronal storage. In some heredi-
tary metabolic diseases related to enzymatic defects
1.1.1.1.4. Vacuolated neurons and neu involving synthetic or degradative pathways for
ropil. Vacuolated neurons and/or vacuolated neu- lipids or carbohydrates, interruption of the pathway
ropil is observed typically in Creutzfeldt-Jakob leads to cytoplasmic accumulation of interme-
disease (Fig. 1.6). In rare instances, swelling with diate substrates or their by-products, resulting in
vacuolization of the nerve cell may result from swelling and distention of the cell body of nerve
transsynaptic degeneration, such as occurs in the cells, with eccentric displacement of the nucleus
neurons of the inferior olive in olivary hypertrophy (Fig. 1.8). In several neuronal storage disorders, the
secondary to a lesion of the ipsilateral central teg- stored material has distinctive histochemical and
mental tract or of the contralateral dentate nucleus; ultrastructural features that may help characterize
this phenomenon is also designated “fenestrated
neurons” (Fig. 1.7).
C D
E F
FIGURE 1.10 Different types of neurofibrillary tangles (Bodian silver impregnation combined with Luxol fast
blue): band-shaped perikaryal NFT (A); triangular flame-shaped perikaryal NFT (B, C); small, compact, glo-
bose perikaryal NFT (D); large globose NFT (E); “ghost NFT” (F).
Lewy bodies are neuronal cytoplasmic inclusions; single neuron (Fig. 1.13A, B). They may also be
their appearance varies according to whether they oval or elongated structures, especially when they
are found in the perikaryon or in the nerve cell occur in axonal processes or in sympathetic gan-
processes, cortex, brainstem, or sympathetic gan- glia (Fig. 1.13C, D). Cortical Lewy bodies are less
glia (Fig. 1.13). Typical (brainstem) Lewy bodies clearly outlined and consist of a homogeneous zone
are roughly spherical with an eosinophilic core of hypereosinophilia that usually lacks the char-
surrounded by a paler “halo.” One or more of these acteristic surrounding halo (Fig. 1.13E, F). Lewy
structures may be present in the cytoplasm of a bodies are immunoreactive for α synuclein as well as
C D
E F
FIGURE 1.13 Lewy bodies (H&E). Single (A) and multiple (B) Lewy body(ies) in the perikaryon of
pigmented neurons of the substantia nigra in a case of Parkinson disease. Lewy bodies in axonal processes (C,
D), in the dorsal nucleus of cranial nerve X in a case of Parkinson s disease. Cortical Lewy bodies (E, F) in the
perikaryon of cortical neurons in a case of Lewy body disease.
inclusions are intracytoplasmic and are referred to be used to identify virions; however, it is now used
as Negri bodies (Fig. 5.30). In rare instances (e.g., less often in diagnostic work.
cytomegalovirus infection; (Fig. 5.38)), both
intranuclear and intracytoplasmic inclusions may 1.1.1.1.9. Axonal alterations. Following ax-
be seen. Viral inclusion bodies are immunoreactive onal lesions that disrupt the integrity and con-
with appropriate antivirus antibodies, allowing for tinuity of the cell process, the distal part of the
a specific diagnosis. Electron microscopy may also axon undergoes Wallerian degeneration, which
A B
FIGURE 1.15 Bunina bodies in anterior horn cells of the spinal cord in a case of motor neuron disease (H&E)
(A); immunocytochemistry for cystatin C (B).
FIGURE 1.17 Intranuclear inclusions: (A) Marinesco bodies: small intranuclear inclusion in a pigmented
neuron of the substantia nigra (H&E); (B) ubiquitin-positive intranuclear inclusion in a case of spinocerebellar
degeneration with CAG repeat expansion. (Courtesy of Professor Francesco Scaravilli.)
dysfunction are usually termed dystrophic. This reactive process accompanies almost any type of
occurs in some acquired (e.g., vitamin E deficiency) subacute or chronic injury of the CNS. The process
or inherited metabolic diseases. Extensive forma- of gliosis is in essence the response of astrocytes to
tion of axonal swellings is an important patholog- CNS tissue injury. The associated morphological
ical manifestation of neuroaxonal dystrophy and of changes include an increase in the number of as-
some leukodystrophies. trocyte nuclei per unit area, eosinophilia of the cy-
The term dystrophic neurite is used to describe toplasm around the nucleus, and expansion and
a neuronal process within the gray matter that distortion of the astrocytic cytoplasmic arboriza-
is distended by tau protein or other abnormal tion. For reasons that are not understood, mitotic
ubiquitinated material. These occur in several neu- figures are only rarely identified in gliotic tissue, and
rodegenerative diseases. techniques that bring out dividing cells (Mib-1/Ki
67) also confirm the slow turnover.
1.1 . 1 . 2 . AS T R OC YTI C L ESI O NS The morphologic aspects of the process of gliosis
will vary depending on the location, stage of evo-
1.1.1.2.1. Gliosis (astrogliosis). The presence lution, and nature of the pathological process. The
of gliosis (alternate term astrogliosis) is the most cer- early stages are characterized by hypertrophy of the
tain indication that a microscopic abnormality is nucleus, which is often hyperchromatic and eccen-
of pathologic significance and not artifactual. This trically placed in the perikaryon. As mentioned, the
cytoplasm around the nucleus and cell processes
become more extensive than normal and are found
to contain glycogen (Fig. 1.20A). Characteristically,
at this stage, in H&E preparations, the cytoplasm
is homogenized and eosinophilic; these reactive
astrocytes are referred to as gemistocytic astrocytes
(Fig. 1.20B, C).
Over time, in chronic disease states and slowly
evolving degenerative processes, astrocyte nuclei re-
turn to their resting size and shape, though their cy-
toplasmic network of cell processes is more extensive
and can best be appreciated with immunostaining
for glial fibrillary acidic protein (GFAP).
An older term, isomorphorphic fibrillary gliosis,
FIGURE 1.18 Lafora body in a case of myoclonic refers to the alignment of reactive astrocyte
epilepsy (periodic acid–Schiff). processes conforming to a degenerating fiber tract.
A B
FIGURE 1.19 Axonal swellings in the white matter identified on silver impregnation (A) (Bodian stain)
and on ubiquitin immunostain (B). Torpedo (axonal swelling) on a Purkinje cell axon identified by β-APP
immunostaining (C).
1.1.1.2.2. Alzheimer type II glia. Alzheimer ultrastructural study, they are shown to contain nu-
type II glia is seen particularly in hyperammonemic merous mitochondria.
states such as occur in Wilson disease and in liver
failure from acquired or hereditary metabolic disease, 1.1.1.2.3. Rosenthal fibers. By light micros-
but can also be found in a variety of other systemic copy, Rosenthal fibers are rounded, oval, or elon-
metabolic disorders (e.g., renal failure). This reac- gated beaded structures measuring 10 to 40 μm
tion of astrocytes is characterized by enlargement of that appear homogeneous and brightly eosinophilic
the nucleus, reaching 15 to 20 μm in diameter, which (Fig. 2.4B). On electron microscopy, they con-
appears irregular in shape and pale and empty looking sist of swollen astrocytic processes that are filled
because of the disappearance of chromatin granules with electron-dense amorphous granular material
(Fig. 1.21). One or two dense, rounded PAS-positive and glial filaments. With immunohistochemical
bodies resembling nucleoli are often seen next to the method peripheral labeling for GFAP, ubiquitin
nuclear membrane, which is always sharply defined. and αB-crystallin can be demonstrated. Rosenthal
The cell body is not usually visible on conventional fibers are seen in various pathological conditions
preparations and stains poorly with GFAP. Alzheimer that have in common intense fibrillary gliosis of
II glia are unrelated to Alzheimer disease; they tend to long standing, as seen throughout the brain in
occur in the gray matter, involving particularly deep multiple sclerosis plaques, in the spinal cord in
gray nuclei, especially the pallidum and the dentate syringomyelia, and in the hypothalamus around
nuclei, and also the cerebral cortex. Alzheimer type craniopharyngiomas. They are also characteristic of
II glia are metabolically active cells engaged in the certain neoplasms (pilocytic astrocytoma, partic-
catabolism of toxic substances such as ammonia; on ularly of the cerebellum, but also elsewhere in the
FIGURE 1.20 Gliosis. Fibrillary gliosis (A) hypertrophy of nucleus and of cytoplasm and processes that
are very visible on GFAP stain. Gemistocytic astrocytes with large homogenized and eosinophilic cytoplasm
(H&E) (B), (GFAP) (C).
brain) (cf. Chapter 2), and in Alexander disease (cf. 1.1.1.2.4. Inclusions and storage mate
Chapter 10). rial. Accumulation of lipofuscin occurs in astrocytes
Eosinophilic granular bodies are rounded hya- as part of aging as it does in neurons. Similarly, in
line droplet aggregates that occupy the cytoplasm lipid storage diseases, glial lipid storage may accom-
of astrocytes and are particularly seen in tumors, pany neuronal storage.
including pilocytic astrocytoma, pleomorphic Tau protein, which is the main component of
xanthoastrocytoma, and ganglion cell tumors. NFTs, can also accumulate in astrocytes, particularly
in PSP and corticobasal degeneration (cf. Chapter 8).
Tufted astrocytes are considered to be highly char-
acteristic of PSP (Fig. 8.20A). The whole length
of their processes contains tau protein, and they
are often binucleated. They may be demonstrated
by Gallyas stain or tau immunocytochemistry. In
corticobasal degeneration, accumulation of tau pro-
tein in astroglia forms distinctive structures in gray
matter areas termed astrocytic plaques: Tau protein
accumulates at the end of the astrocytic processes,
while the center of the plaque is devoid of tau
immunoreactivity (Fig. 8.23).
Thorn-shaped astrocytes and have an argyrophilic
FIGURE 1.21 Alzheimer type II glial cells (H&E). cytoplasm with a few short processes (Fig. 8.20B)
FIGURE 1.23 Perivascular lipid-laden macrophages (compound granular corpuscles, foam cells, or gitter
cells) in a demyelinating lesion (Luxol fast blue combined with Bodian silver impregnation) (A) and with CD68
immunostaining) (B).
1. 1. 2. 1. C ER EBR AL ATR OP HY
Cerebral atrophy is the end stage of a number of
neurological diseases. The brain is lighter than a
FIGURE 1.24 Rod-shaped microglia in a case of normal age-matched control. Macroscopically, there
general paresis of the insane (Nissl stain). is narrowing of the gyri and widening of sulci. On
Our website is not just a platform for buying books, but a bridge
connecting readers to the timeless values of culture and wisdom. With
an elegant, user-friendly interface and an intelligent search system,
we are committed to providing a quick and convenient shopping
experience. Additionally, our special promotions and home delivery
services ensure that you save time and fully enjoy the joy of reading.
textbookfull.com